Treatment of advanced or metastatic hepatocellular cancer (HCC): Final clinical results of a single-arm phase II study of bevacizumab and everolimus

被引：0

作者：

Treiber, Gerhard

Wex, Thomas

Schneider, Guenther

Roecken, Cristoph

Dufour, Jean-Francois

Geisel, Juergen

Hardikar, S.

机构：

[1] Zollernalb Clin, Dept Internal Med, Balingen, Germany

[2] Otto von Guericke Univ Hosp, Clin Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany

[3] Saarland Univ Hosp, Dept Diagnost & Intervent Radiol, Homburg, Germany

[4] Univ Kiel, Inst Pathol, Kiel, Germany

[5] Univ Bern, Dept Clin Pharmacol, Bern, Switzerland

[6] Saarland Univ Hosp, Dept Clin Chem, Homburg, Germany

[7] Novartis Asia Pacific Pharmaceut, Singapore, Singapore

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4107

引用

页数：1

共 50 条

[21] Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
Pelster, Meredith S.
Gruschkus, Stephen K.
Bassett, Roland
Gombos, Dan S.
Shephard, Michael
Posada, Liberty
Glover, Maura S.
Simien, Rinata
Diab, Adi
Hwu, Patrick
Carter, Brett W.
Patel, Sapna P.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 599 - +
[22] Phase II trial of bevacizumab and everolimus in the treatment of patients with metastatic melanoma: Preliminary results
Peyton, J. D.
Spigel, D. R.
Burris, H. A.
Lane, C.
Rubin, M.
Browning, M.
Trent, D.
Hainsworth, J. D.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[23] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
Huang, Nai-si
Wei, Wen-jun
Xiang, Jun
Chen, Jia-ying
Guan, Qing
Lu, Zhong-wu
Ma, Ben
Sun, Guo-hua
Wang, Yu-long
Ji, Qing-hai
Wang, Yu
THYROID, 2021, 31 (12) : 1808 - 1813
[24] Sources of bias for single-arm phase II cancer clinical trials
Jung, Sin-Ho
ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
[25] Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study
Straume, Oddbjorn
Schuster, Cornelia
Puntervoll, Hanne
Eikesdal, Hans P.
Heinrich, Daniel
Geisler, Stephanie B.
Geisler, Jurgen
Molven, Anders
Lonning, Per E.
Akslen, Lars
CANCER RESEARCH, 2012, 72
[26] Toripalimab combined with bevacizumab and chemotherapy for refractory, recurrent or metastatic cervical cancer: preliminary results of a single-arm, open-label, phase II trial
Peng, Peng
Yao, Hairong
Liu, Dantong
He, Yonglan
Liu, Shikai
Xiang, Yang
GYNECOLOGIC ONCOLOGY, 2023, 176 : S29 - S29
[27] A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer
Huang, Jia-Yi
Xie, Xiao-Feng
Chen, Xue-Lian
Zhang, Qiu-Yi
Chen, Li-Ping
Bai, Xue
Lan, Xiao-Feng
Song, Lin
Guo, Jin-Feng
Du, Cai-Wen
FRONTIERS IN ONCOLOGY, 2023, 13
[28] Bevacizumab plus trifluridine/tipiracil in elderly patients with previously untreated metastatic colorectal cancer (KSCC 1602): A single-arm, phase II study
Makiyama, A.
Oki, E.
Miyamoto, Y.
Kotaka, M.
Kawanaka, H.
Miwa, K.
Kabashima, A.
Noguchi, T.
Yuge, K.
Kashiwada, T.
Shimokawa, M.
Saeki, H.
Akagi, Y.
Baba, H.
Mori, M.
ANNALS OF ONCOLOGY, 2019, 30
[29] Final results of a phase 1 evaluation of niraparib and everolimus in advanced ovarian and metastatic breast cancer
Rojas-Espaillat, Luis
Starks, David
Williams, Casey
GYNECOLOGIC ONCOLOGY, 2022, 166 : S159 - S159
[30] Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab (BEV), carboplatin (C) and paclitaxel (P) for advanced cervical cancer (aCC)
Redondo, A.
Colombo, N.
Dreosti, L. M.
McCormack, M.
Nogueira Rodrigues, A.
Scambia, G.
Roszak, A.
Donica, M.
Ulker, B.
Gonzalez Martin, A.
ANNALS OF ONCOLOGY, 2019, 30 : 429 - 429

← 1 2 3 4 5 →